Cargando…
In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
Interest has emerged in biased agonists at the mu opioid receptor (MOR) as a possible means for maintaining potent analgesis with reduced side effect profiles. While approaches measuring in vitro biased agonism are used in the development of these compounds, their therapeutic utility will ultimately...
Autores principales: | Zhang, Xiao, Hutchins, Shaurita D., Blough, Bruce E., Vallender, Eric J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312292/ https://www.ncbi.nlm.nih.gov/pubmed/32503269 http://dx.doi.org/10.3390/ijms21113999 |
Ejemplares similares
-
Biased Signaling of the Mu Opioid Receptor Revealed in Native Neurons
por: Ehrlich, Aliza T., et al.
Publicado: (2019) -
Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl
por: Tian, Xiangyun, et al.
Publicado: (2022) -
Anti-Analgesic Effect of the Mu/Delta Opioid Receptor Heteromer Revealed by Ligand-Biased Antagonism
por: Milan-Lobo, Laura, et al.
Publicado: (2013) -
Dezocine is a Biased Ligand without Significant Beta-Arrestin Activation of the mu Opioid Receptor
por: Grothusen, John, et al.
Publicado: (2022) -
Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)